Ausgabe 6/2019
Inhalt (17 Artikel)
Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives
T. Mocan, Z. Sparchez, R. Craciun, C. N. Bora, D. C. Leucuta
Cancer immunotherapy of patients with HIV infection
M. Gonzalez-Cao, J. Martinez-Picado, N. Karachaliou, R. Rosell, A. Meyerhans
Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients’ preference-based study (PPPS)
Y. Zhao, G. Qiao, X. Wang, Y. Song, X. Zhou, N. Jiang, L. Zhou, H. Huang, J. Zhao, M. A. Morse, A. Hobeika, J. Ren, H. K. Lyerly
The burden of cancer in Spain
X. Badía, M. Tort, A.-G. Manganelli, C. Camps, E. Díaz-Rubio
Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)
F. Couñago, S. Montemuiño, M. Martin, B. Taboada, P. Calvo-Crespo, M. P. Samper-Ots, P. Alcántara, J. Corona, J. L. López-Guerra, M. Murcia-Mejía, M. López-Mata, J. Jové-Teixidó, M. Chust, V. Díaz-Díaz, L. de Ingunza-Barón, T. García-Cañibano, M. L. Couselo, E. del Cerro, J. Moradiellos, S. Amor, A. Varela, M. M. Puertas, I. J. Thuissard, D. Sanz-Rosa, N. R. de Dios
The protective effects of melatonin on blood cell counts of rectal cancer patients following radio-chemotherapy: a randomized controlled trial
N. Kouhi Habibi, A. Shabestani Monfared, K. Ebrahimnejad Gorji, M. Karimi, A. A. Moghadamnia, M. Tourani, S. Borzoueisileh, F. Niksirat
Laparoscopy adjuvant total colorectal resection for the treatment of familial adenomatous polyposis (FAP)
Z. Zhang, D. Wang, C. Xu, Y. Yu, Y. Li, X. Zhang
Oncologic outcomes of nephron-sparing surgery in patients with T1 multifocal renal cell carcinoma
G. Li, D. Zhu, H. Gao, H. Chen, Y. Li, Y. Niu
Diagnostic performance of 18F-choline PET-CT in prostate cancer
P. Samper Ots, A. Luis Cardo, C. Vallejo Ocaña, M. A. Cabeza Rodríguez, L. A. Glaria Enríquez, M. L. Couselo Paniagua, J. Olivera Vegas
Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy
M. Bloemendal, M. J. A. Rietveld, W. W. van Willigen, W. R. Gerritsen, C. G. Figdor, J. J. Bonenkamp, H. Westdorp, S. Boudewijns, R. H. T. Koornstra, E. M. M. Adang, G. Schreibelt, P. B. Ottevanger, I. J. M. de Vries, K. F. Bol
Omitting the lower neck and sparing the glottic larynx in node-negative nasopharyngeal carcinoma was safe and feasible, and improved patient-reported voice outcomes
F. Xiao, S. Dou, Y. Li, W. Qian, F. Liang, L. Kong, X. Wang, K. Wu, C. Hu, G. Zhu
Metronomic oral vinorelbine for the treatment of advanced non-small cell lung cancer: a multicenter international retrospective analysis
A. Camerini, G. L. Banna, S. Cinieri, A. Pezzuto, M. Mencoboni, F. Rosetti, A. Figueiredo, P. Rizzo, A. Ricci, L. Langenhoven, A. Santo, A. Addeo, D. Amoroso, F. Barata
Active surveillance as a successful management strategy for patients with clinical stage I germ cell testicular cancer
R. Escudero-Ávila, J. D. Rodríguez-Castaño, I. Osman, F. Fernandez, R. Medina, B. Vargas, M. Japón-Rodríguez, P. Sancho, B. Perez-Valderrama, J. M. Praena-Fernández, I. Duran
Improvement of appropriate pharmacological prophylaxis in hospitalised cancer patients with a multiscreen e-alert system: a single-centre experience
R. Figueroa, A. Alfonso, J. López-Picazo, I. Gil-Bazo, A. García-Mouriz, J. Hermida, J. A. Páramo, R. Lecumberri
Statin treatment and outcomes of metastatic pancreatic cancer: a pooled analysis of two phase III studies
O. Abdel-Rahman
Correction to: SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016)
M. Lázaro, E. Gallardo, M. Doménech, Á. Pinto, A. González-del-Alba, J. Puente, O. Fernández, A. Font, N. Lainez, S. Vázquez